3
Shared Docs
3
Same-Page
4 / 3
Mentions
From: To: Jeffrey epstein <jeevacatiokariginail.corn>, Richard Kahn Subject: moving forward Date: Wed, 19 Feb 2014 20:55:03 +0000 Hi Jeffrey and Rich, I received Rich's emai
From: To: Jeffrey epstein <jeevacatiokariginail.corn>, Richard Kahn Subject: moving forward Date: Wed, 19 Feb 2014 20:55:03 +0000 Hi Jeffrey and Rich, I received Rich's email to Tyler. My reaction is the following: I think you should certainly continue for 60 days and then stop definitiv
raft a featured article when needed, Ill have the liberty of using Jeffrey's name in the title and I'll have the leverage to publish elsewhere. With Ntl Review for example, I published an article but was not allowed to use Jeffrey's name— a contributing writer position gives you that freedom. If I didn't s
To: [email protected][ ] Cc: jeffrey epstein '[email protected]) From: Sent: Mon 8/5/2013 10:40:56 PM Subject: redraft of the PED Hi Tyler, I could do a redraft of my Ntl Review article
jeffrey epstein '[email protected]) From: Sent: Mon 8/5/2013 10:40:56 PM Subject: redraft of the PED Hi Tyler, I could do a redraft of my Ntl Review article for the Huffington-- or Forbes--but would need to put someone's name on it other than my own. let me know if I can use someone's name from
From: Sent: Wednesday, February 19, 2014 8:55 PM To: jeffrey epstein; Richard Kahn Subject: moving forward Hi Jeffrey and =ich, I received Rich's email to Tyler. My reactio= is the following: I think you should certainly c=ntinue for 60 days and then stop definitiv
aft a featured article when needed, I'll have th= liberty of using Jeffrey's name in the title and I'll have the lever=ge to publish elsewhere. With Ntl Review for example, I published an artic=e but was not allowed to use Jeffrey's name-- a contributing writer positi=n gives you that freedom. If I didn't
Entities connected to both Jeffrey Epstein and Ntl Review